×
QuidelOrtho EBIT 2010-2025 | QDEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
QuidelOrtho ebit from 2010 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
QuidelOrtho EBIT 2010-2025 | QDEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
QuidelOrtho ebit from 2010 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$228.8B
Boston Scientific (BSX)
$153.1B
Stryker (SYK)
$149.1B
EssilorLuxottica (ESLOY)
$130.1B
Medtronic (MDT)
$114.4B
Lonza Group Ag (LZAGY)
$49.2B
Haleon (HLN)
$43.7B
ResMed (RMD)
$37B
GE HealthCare Technologies (GEHC)
$34.1B
Agilent Technologies (A)
$32.1B
Terumo (TRUMY)
$24.2B
Koninklijke Philips (PHG)
$23.2B
Insulet (PODD)
$20.4B
Zimmer Biomet Holdings (ZBH)
$18.6B
Baxter (BAX)
$14.5B
Smith & Nephew SNATS (SNN)
$12.8B
Demant (WILYY)
$8.6B
Sunny Optical Technology (SNPTF)
$8.6B
Bio-Rad Laboratories (BIO)
$6.7B
Lantheus Holdings (LNTH)
$5.6B
Perrigo (PRGO)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.7B
Haemonetics (HAE)
$3.6B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Envista Holdings (NVST)
$3.4B
ICU Medical (ICUI)
$3.1B
LeMaitre Vascular (LMAT)
$1.9B
AtriCure (ATRC)
$1.5B
Acuren (TIC)
$1.4B
Green Thumb Industries (GTBIF)
$1.2B